These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4356014)

  • 1. Antiarrhythmic and electrophysiologic properties of UM-272, dimethyl quaternary propranolol, in the canine heart.
    Kniffen FJ; Schuster DP; Lucchesi BR
    J Pharmacol Exp Ther; 1973 Nov; 187(2):260-8. PubMed ID: 4356014
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiarrhythmic and general cardiovascular activity of the N,N-dimethylquaternary ammonium derivative of bunolol.
    Kaplan HR; Barker JW; Dugan D; Fox J; Giardino E
    Arch Int Pharmacodyn Ther; 1974 Jan; 207(1):28-43. PubMed ID: 4151048
    [No Abstract]   [Full Text] [Related]  

  • 3. The antiarrhythmic properties of ICI 46037, a quaternary analog of propranolol.
    Lucchesi BR; Iwami T
    J Pharmacol Exp Ther; 1968 Jul; 162(1):49-59. PubMed ID: 4297801
    [No Abstract]   [Full Text] [Related]  

  • 4. The antiarrhythmic properties of UM-272, the dimethyl quaternary derivative of propranolol.
    Schuster DP; Lucchesi BR; Nobel NL; Mimnaugh MN; Counsell RE; Kniffen FJ
    J Pharmacol Exp Ther; 1973 Jan; 184(1):213-27. PubMed ID: 4405548
    [No Abstract]   [Full Text] [Related]  

  • 5. Electrophysiologic actions of UM-272 (Pranolium) on reentrant ventricular arrhythmias in postinfarction canine myocardium.
    Gibson JK; Lucchesi BR
    J Pharmacol Exp Ther; 1980 Aug; 214(2):347-53. PubMed ID: 7391982
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cellular mechanism of the antiarrhythmic action of propranolol].
    Kwiatkowska B; Czarnecka M; Lewartowski B
    Acta Physiol Pol; 1970; 21(4):441-54. PubMed ID: 5452921
    [No Abstract]   [Full Text] [Related]  

  • 7. A microelectrophysiological analysis of the pharmacodynamic basis for quinidine-propranolol antiarrhythmic potentiation.
    Iansmith DH; Bandura JP; Nash CB
    J Pharmacol Exp Ther; 1981 Dec; 219(3):651-8. PubMed ID: 7299688
    [No Abstract]   [Full Text] [Related]  

  • 8. Electrophysiologic effects of 3-(p-chlorophenyl)-(2-imadazolin-2-yl-methyl)-1,2,3,4-tetrahydro-1-benzepine hydrochloride (SU-13197), a new antiarrhythmic agent.
    Watanabe Y; Dreifus LS
    J Pharmacol Exp Ther; 1968 Jan; 159(1):146-52. PubMed ID: 5643942
    [No Abstract]   [Full Text] [Related]  

  • 9. Is the antiarrhythmic effects of PA related to wavelength?
    Tribulova N; Manoach M
    Circulation; 1999 Apr; 99(16):2220-1. PubMed ID: 10217701
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of dehydrobenzperidol, quinidine and propranolol on the effective refractory time and spontaneous impulse formation of guinea pig atria].
    Schaer H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):193. PubMed ID: 4239223
    [No Abstract]   [Full Text] [Related]  

  • 11. [The antiarrhythmic activity of the trimecain ammonium derivative in myocardial ischemia].
    Kostin IaV; Blinov DS; Moiseeva IIa
    Eksp Klin Farmakol; 2003; 66(3):29-31. PubMed ID: 12924229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmias and antiarrhythmic drugs.
    Bigger JT
    Adv Intern Med; 1972; 18():251-81. PubMed ID: 4576083
    [No Abstract]   [Full Text] [Related]  

  • 13. Clofilum--a new antifibrillatory agent that selectively increases cellular refractoriness.
    Steinberg MI; Molloy BB
    Life Sci; 1979 Oct; 25(16):1397-406. PubMed ID: 522607
    [No Abstract]   [Full Text] [Related]  

  • 14. N-n-propyl-ajmaline-bitartrate (NPAB), a new antiarrhythmic drug. Comparative studies on the antifibrillatory and hemodynamic effects in the anaesthetised cat.
    Diederich KW; Boyksen D
    Arzneimittelforschung; 1973 Sep; 23(9):1302-5. PubMed ID: 4801225
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of diphenylhydantoin on electrophysiological properties of the canine heart.
    Rosati RA; Alexander JA; Schaal SF; Wallace AG
    Circ Res; 1967 Nov; 21(5):757-65. PubMed ID: 6073567
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical electrophysiology of ventricular tachycardia.
    Prystowsky EN; Heger JJ; Lloyd EA; Zipes DP
    Cardiol Clin; 1983 May; 1(2):253-73. PubMed ID: 6544638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The mechanism of antiarrhythmic action of a new ammonium derivative of lidocaine (LKhT-12-02)].
    Blinov DS; Balashov VP; Sernov LN; Kazachenko VN; Blinova EV; Belova LA; Astashev ME
    Eksp Klin Farmakol; 2006; 69(6):31-3. PubMed ID: 17209461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative studies on heart-lung-preparation of dog. Effect of various antiarrhythmic active substances on the contractility, rate of conductivity, refractory phase and excitability of heart].
    Igarashi T; Shyoji T
    Arzneimittelforschung; 1968 Nov; 18(11):1368-72. PubMed ID: 5755899
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of ventricular fibrillation induced by coronary ligation.
    Kaumann AJ; Aramendía P
    J Pharmacol Exp Ther; 1968 Dec; 164(2):326-32. PubMed ID: 5699094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.